ConductScience.org, home

Paper39768461

Long-Term Survival of Methotrexate as First-Line Therapy in Rheumatoid Arthritis, Psoriatic Arthritis and Undifferentiated Arthritis.

Perrotta FM and 2 others. J Clin Med, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Long-Term Survival of Methotrexate as First-Line Therapy in Rheumatoid Arthritis, Psoriatic Arthritis and Undifferentiated Arthritis. Papers, record 39768461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39768461

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long-Term Survival of Methotrexate as First-Line Therapy in Rheumatoid Arthritis, Psoriatic Arthritis and Undifferentiated Arthritis.
PubMed
Journal
J Clin Med
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
1.01, provisional
iCite
Revised in PubMed
2025-01-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Perrotta FMFabio Massimohttps://orcid.org/0000-0003-3771-5205
2Ambrosino PPasqualehttps://orcid.org/0000-0002-9398-0428
3Lubrano EEnniohttps://orcid.org/0000-0001-6189-5328

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
not applicableRicerca Corrente" funding scheme of the Ministry of HealthPubMed

Source PubMed

Download CSV of grants

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14037555Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.Ann Intern Med1985https://conductscience.org/library/papers/4037555PubMed
23883172Efficacy of low-dose methotrexate in rheumatoid arthritis.N Engl J Med1985https://conductscience.org/library/papers/3883172PubMed
319740904Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.Ann Rheum Dis2010https://conductscience.org/library/papers/19740904PubMed
411838843Disease modifying antirheumatic drugs in early rheumatoid arthritis: a longterm observational study.J Rheumatol2002https://conductscience.org/library/papers/11838843PubMed
518064739The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.Lancet2007https://conductscience.org/library/papers/18064739PubMed
614677172Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis.J Rheumatol2003https://conductscience.org/library/papers/14677172PubMed
735761070Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021.Nat Rev Rheumatol2022https://conductscience.org/library/papers/35761070PubMed
88235288Long-term experience with low dose methotrexate in rheumatoid arthritis.Rheumatol Int1993https://conductscience.org/library/papers/8235288PubMed
916871531Classification criteria for psoriatic arthritis: development of new criteria from a large international study.Arthritis Rheum2006https://conductscience.org/library/papers/16871531PubMed
1019633799[Long-term survival of methotrexate in psoriatic arthritis].Reumatismo2009https://conductscience.org/library/papers/19633799PubMed
1136933068Long-term persistence of oral methotrexate and associated factors in rheumatoid arthritis: a retrospective cohort study.Rheumatol Int2023https://conductscience.org/library/papers/36933068PubMed
1231474599Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.J Rheumatol2020https://conductscience.org/library/papers/31474599PubMed
1330747501Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial.Arthritis Rheumatol2019https://conductscience.org/library/papers/30747501PubMed
1415208176Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities.Ann Rheum Dis2005https://conductscience.org/library/papers/15208176PubMed
156394758A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis.J Rheumatol1984https://conductscience.org/library/papers/6394758PubMed
1622344575A randomized placebo-controlled trial of methotrexate in psoriatic arthritis.Rheumatology (Oxford)2012https://conductscience.org/library/papers/22344575PubMed
1726470835An overview of low disease activity and remission in psoriatic arthritis.Clin Exp Rheumatol2015https://conductscience.org/library/papers/26470835PubMed
1823221588ACR/EULAR 2010 rheumatoid arthritis classification criteria.Rheumatology (Oxford)2012https://conductscience.org/library/papers/23221588PubMed
1911454634Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis.Ann Rheum Dis2001https://conductscience.org/library/papers/11454634PubMed
208646436Effect of age on the efficacy and tolerance of methotrexate in rheumatoid arthritis.Br J Rheumatol1996https://conductscience.org/library/papers/8646436PubMed

See all 25 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42307638Pharmacological assessment of drugs retained in the 1st and 24th WHO Essential Medicines List (1977-2025).Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42307638PubMed
41836019Clinical characteristics and risk factors of severe myelosuppression in rheumatoid arthritis patients with csDMARD non-adherence: a case series.Front Pharmacol2026https://conductscience.org/library/papers/41836019PubMed
41658163ROS-Scavenging Bamboo-Derived Carbon Dot-Methotrexate Nanocomposite Ameliorates Rheumatoid Arthritis through Dual Therapeutic Mechanisms.ACS Omega2026https://conductscience.org/library/papers/41658163PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39768461

GET https://conductscience.org/api/papers/v1/39768461/references?page=2